Wikipedia -WSS

Wikipedia

author：explore 2025-09-03 09:23:39 - browse：23

An ALS patient receives support. -- health coverage from STAT — Adobe

Years of polarizing scientific discourse and bruising online debate will come to a head next week when advisers to the Food and Drug Administration weigh in on NurOwn, a potential treatment to slow the progression of ALS that has bitterly divided physicians and patient advocates.

On Sept. 27, a panel of experts will consider the convoluted data supporting the potential approval of NurOwn, a stem-cell therapy the FDA previously refused to even consider. To some physicians, the drug’s failure to show significant benefits in clinical studies leaves approval out of the question. Others, including the influential ALS Association, say NurOwn’s manufacturer, a small biotech firm called BrainStorm Cell Therapeutics, hasn’t disclosed enough information to properly determine the medicine’s value.

Another group of patients and doctors argue that NurOwn’s supporting evidence, while problematic, justifies making it available to the roughly 30,000 ALS patients in the U.S., people for whom there is currently no hope of arresting an incurable disease that gradually erodes motor function and leads to death within about five years of diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Google's generative AI to analyze medical images — and talk to docs

WSS

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu in dairy cattle: New measures to control spread to humans

Paxlovid rebound happens. Why and to whom are still a mystery

Tuberculosis patients need more than just free medication

Bird flu in dairy cattle: New measures to control spread to humans

Bird flu in dairy cattle: New measures to control spread to humans

explore

Wikipedia

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sweden knocks USA out of World Cup in penalty kicks

How one medical school became remarkably diverse

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Florida Supreme Court upholds state's abortion ban

Virginia high school admissions case could be legal follow

Study: Black kids more likely to die after surgery than white kids

Tori Bowie and the unacceptable rates of Black maternal death

Multiple sclerosis has subtypes with different best treatments: study

focus

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Drug companies' payments and gifts affect physicians' prescribing

Overprescribed: High cost isn't America's only drug problem

Medicare Advantage 2025 payments will dip, Biden administration says

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Young boy dies in trial for Pfizer Duchenne gene therapy

entertainment

hotspot

focus

focus